ScientistVedanta BiosciencesSomerville, Massachusetts, United States
Disclosure(s): Vedanta Biosciences: Employment, Stocks/Bonds (Private Company)
377 - Impact of VE303, a Defined Bacterial Consortium, on Antimicrobial Resistant Gene Prevalence in Patients with Clostridioides difficile Infection (CDI)
Friday, October 18, 20241:57 PM – 2:09 PM US PT